JAK2 and cholangiocarcinoma: As shown in Figure 5D,E and Figure S4, the levels of phosphorylated JAK2 and phosphorylated STAT3 in CCA cells pretreated with 75% PA-CM prior to IL-6 treatment decreased compared to CCA cells treated with IL-6 alone.